148 related articles for article (PubMed ID: 15001936)
1. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants.
Letson GW; Shapiro CN; Kuehn D; Gardea C; Welty TK; Krause DS; Lambert SB; Margolis HS
J Pediatr; 2004 Mar; 144(3):327-32. PubMed ID: 15001936
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.
Bell BP; Negus S; Fiore AE; Plotnik J; Dhotre KB; Williams J; Shapiro CN; McMahon BJ
Pediatr Infect Dis J; 2007 Feb; 26(2):116-22. PubMed ID: 17259872
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
[TBL] [Abstract][Full Text] [Related]
4. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.
Sharapov UM; Bulkow LR; Negus SE; Spradling PR; Homan C; Drobeniuc J; Bruce M; Kamili S; Hu DJ; McMahon BJ
Hepatology; 2012 Aug; 56(2):516-22. PubMed ID: 22371069
[TBL] [Abstract][Full Text] [Related]
5. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules.
López EL; Contrini MM; Xifró MC; Cattaneo MA; Zambrano B; Dumas R; Rouyrre N; Weber F
Vaccine; 2007 Jan; 25(1):102-8. PubMed ID: 16914234
[TBL] [Abstract][Full Text] [Related]
7. Decline of maternal hepatitis a antibodies during the first 2 years of life in infants born in Turkey.
Derya A; Necmi A; Emre A; Akgün Y
Am J Trop Med Hyg; 2005 Aug; 73(2):457-9. PubMed ID: 16103622
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
10. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E
Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Dagan R; Greenberg D; Weber F
Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
[TBL] [Abstract][Full Text] [Related]
12. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
[TBL] [Abstract][Full Text] [Related]
14. Decline of maternal hepatitis A virus antibody levels in infants.
De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C
Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V; Herzog C; Genton B
J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
[TBL] [Abstract][Full Text] [Related]
16. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
[TBL] [Abstract][Full Text] [Related]
17. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up.
Wang XY; Xu ZY; Ma JC; von Seidlein L; Zhang Y; Hao ZY; Han OP; Zhang YL; Tian MY; Ouyang PY; Zhang ZY; Han CQ; Xing ZC; Chen JC
Vaccine; 2007 Jan; 25(3):446-9. PubMed ID: 16949710
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study.
Faridi MM; Shah N; Ghosh TK; Sankaranarayanan VS; Arankalle V; Aggarwal A; Sathiyasekaran M; Bhattacharya N; Vasanthi T; Chatterjee S; Choudhury J; Mitra M
Indian Pediatr; 2009 Jan; 46(1):29-34. PubMed ID: 19179715
[TBL] [Abstract][Full Text] [Related]
19. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years.
Van Der Wielen M; Vertruyen A; Froesner G; Ibáñez R; Hunt M; Herzog C; Van Damme P
Pediatr Infect Dis J; 2007 Aug; 26(8):705-10. PubMed ID: 17848882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
